InvestorsHub Logo
Followers 62
Posts 7582
Boards Moderated 1
Alias Born 01/02/2003

Re: None

Wednesday, 10/26/2022 11:49:25 AM

Wednesday, October 26, 2022 11:49:25 AM

Post# of 427301
I am anticipating information on several important items at tomorrow's C.C, including an interest in Amarin's plans for MND-2119...e.g.. what dividends are due to Mochida for its use and does Amarin have plans to present MND-2119 to the FDA for approval and does it also have plans to include it in a fixed dose combo with a statin.

I would also appreciate hearing news about Amarin's response to Denner's proxy initiative.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News